Acalabrutinib Impurity 50 - Request Quote
Acalabrutinib Impurity 50
| SZ CAT No: | SZ-A078083 |
| CAS No | NA |
| Mol.F. | C29H24N6O4 |
| Mol.Wt. | 520.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Acalabrutinib Impurity 50 is chemically Benzyl 4-((7-((benzyloxy)carbonyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methyl)-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate. Acalabrutinib Impurity 50 is supplied with detailed characterization data compliant with regulatory guideline. Acalabrutinib Impurity 50 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Acalabrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Acalabrutinib Impurity 50
Purchase Acalabrutinib Impurity 50
Acalabrutinib Impurity 50 suppliers
Acalabrutinib Impurity 50 manufacturers
Acalabrutinib Impurity 50 price
Order Acalabrutinib Impurity 50
Enquire Acalabrutinib Impurity 50
Acalabrutinib Impurity 50 cost
Acalabrutinib Impurity 50 Supplier
Acalabrutinib Impurity 50 Distributor
Acalabrutinib Impurity 50 for Method Validation
Acalabrutinib Reference Standard
Acalabrutinib Impurity 50 for ANDA Filing
Acalabrutinib Impurity 50 for Forced Degradation Studies
Acalabrutinib Impurity 50 Identification Standards
Acalabrutinib Impurity 50 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.